Jeoungeun John Park

Dr. Jeoungeun John Park

St. Jude Children's Research Hospital, Memphis, Florida, USA
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 November 2021 in Science Translational Medicine
Verified
Journal Article
Closed access
BPBrooke Prinzing
Brooke Prinzing
CZCaitlin C. Zebley
Caitlin C. Zebley
CPChristopher T. Petersen
Christopher T. Petersen
YFYiping Fan
Yiping Fan
AAAlejandro Allo Anido
Alejandro Allo Anido
GKGiedre Krenciute
Giedre Krenciute
DNMT3A deletion preserves CAR T cell functionality during prolonged stimulation.

15 October 2017 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
SKSeunghyun Kim
Seunghyun Kim
EEEllis R. Easterling
Ellis R. Easterling
LPLauren C. Price
Lauren C. Price
SSSavannah L. Smith
Savannah L. Smith
JCJohn E Coligan
John E Coligan
LMLinda K. Myers
Linda K. Myers
Several observations implicate a critical role for T cell dysregulation as a central problem in rheumatoid arthritis. We investigated a mechanism for suppressing T cell activation by stimulating a natural inhibitory receptor called leukocyte-associated Ig-like receptor-1 (LAIR-1). The collagen-induced arthritis (CIA) model and DR-1 transgenic mice were used to study the importance of LAIR-1 in autoimmune arthritis. Splenocytes from wild-type or LAIR-1−/− mice were stimulated with soluble anti-CD3 Ab in the presence or absence of α1(II) and supernatants were collected for cytokine analysis. B6.DR1 mice were immunized with type II collagen/CFA to induce arthritis and were treated with either the stimulatory mAb to LAIR-1 or a hamster IgG control. Finally, B6.DR1/LAIR-1−/− and B6.DR1/LAIR-1+/+ mice were challenged for CIA and mean severity scores were recorded thrice weekly. Using splenocytes or purified CD4+ cells that were sufficient in LAIR-1, CD3-induced cytokine secretion was significantly suppressed in the presence of collagen, whereas LAIR-1–deficient splenocytes had no attenuation. Treatment with a stimulatory mAb to LAIR-1 also significantly attenuated CIA in the LAIR+/+ mice. When B6.DR1/LAIR-1−/− mice were immunized with type II collagen they developed more severe arthritis and had a greater percentage of affected limbs than the wild-type mice. These data demonstrate that collagen can suppress the T cell cytokine response through the action of LAIR-1. Treatment with stimulating LAIR-1 Abs suppresses CIA whereas B6.DR1/LAIR-1−/− mice develop more severe arthritis than wild-type controls. These data suggest that LAIR-1 may be a potential therapeutic target for suppressing rheumatoid arthritis.

1 June 2017 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
KUKirtikumar Upadhyay
Kirtikumar Upadhyay
JPJeoungeun John Park
Jeoungeun John Park
TYTae Won Yoon
Tae Won Yoon
PHPriyanka Halder
Priyanka Halder
YKYoung-In Kim
Young-In Kim
AYAe-Kyung Yi
Ae-Kyung Yi
Group B streptococci (GBS) are one of the leading causes of life-threatening illness in neonates. Proinflammatory responses to GBS mediated through host innate immune receptors play a critical role in the disease manifestation. However, the mechanisms involved in proinflammatory responses against GBS, as well as the contribution of signaling modulators involved in host immune defense, have not been fully elucidated. In the present study, we investigated the role of protein kinase D (PKD)1 in the proinflammatory responses to GBS. We found that both live and antibiotic-killed GBS induce activation of PKD1 through a pathway that is dependent on the TLR signaling adaptor MyD88 and its downstream kinase IL-1R–associated kinase 1, but independent of TNFR-associated factor 6. Our studies using pharmacological PKD inhibitors and PKD1-knockdown macrophages revealed that PKD1 is indispensable for GBS-mediated activation of MAPKs and NF-κB and subsequent expression of proinflammatory mediators. Furthermore, systemic administration of a PKD inhibitor protects d-galactosamine–sensitized mice from shock-mediated death caused by antibiotic-killed GBS. These findings imply that PKD1 plays a critical regulatory role in GBS-induced proinflammatory reactions and sepsis, and inhibition of PKD1 activation together with antibiotic treatment in GBS-infected neonates could be an effective way to control GBS diseases.

Verified
Journal Article
Open access
PDF file
LMLinda K. Myers
Linda K. Myers
YOYing-Xin Ouyang
Ying-Xin Ouyang
JPJay R. Patel
Jay R. Patel
HOHerman H. Odens
Herman H. Odens
VWVirginia Woo-Rasberry
Virginia Woo-Rasberry
AKAndrew H. Kang
Andrew H. Kang
Citrullination of proteins plays an important role in protein function and it has recently become clear that citrullinated proteins play a role in immune responses. In this study we examined how citrullinated collagen, an extracellular matrix protein, affects T-cell function during the development of autoimmune arthritis. Using an HLA-DR1 transgenic mouse model of rheumatoid arthritis, mice were treated intraperitoneally with either native type I collagen (CI), citrullinated CI (cit-CI), or phosphate buffered saline (PBS) prior to induction of autoimmune arthritis. While the mice given native CI had significantly less severe arthritis than controls administered PBS, mice receiving cit-CI had no decrease in the severity of autoimmune arthritis. Using Jurkat cells expressing the inhibitory receptor leukocyte-associated immunoglobulin-like receptor-1 (LAIR-1), Western blot analysis indicated that while CI and cit-CI bound to LAIR-1 with similar affinity, only CI induced phosphorylation of the LAIR ITIM tyrosines; cit-CI was ineffective. These data suggest that cit-CI acts as an antagonist of LAIR-1 signaling, and that the severity of autoimmune arthritis can effectively be altered by targeting T cells with citrullinated collagen.

Verified
Journal Article
Open access
PDF file
LMLinda K. Myers
Linda K. Myers
MWMichael Winstead
Michael Winstead
JKJohn D. Kee
John D. Kee
JPJeoungeun John Park
Jeoungeun John Park
Sicheng ZhangSicheng Zhang
Sicheng Zhang
AKAndrew H. Kang
Andrew H. Kang
Vitamin D plays a crucial role in regulation of the immune response. However, treatment of autoimmune diseases with 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] doses sufficient to be effective is prohibitive due to its calcemic and toxic effects. We use the collagen-induced arthritis (CIA) model to analyze the efficacy of the noncalcemic analog of vitamin D, 20S-hydroxyvitamin D3 [20S(OH)D3], as well as 1,25(OH)2D3, to attenuate arthritis and explore a potential mechanism of action. Mice fed a diet deficient in vitamin D developed a more severe arthritis characterized by enhanced secretion of T cell inflammatory cytokines, compared to mice fed a normal diet. The T cell inflammatory cytokines were effectively suppressed, however, by culture of the cells with 20S(OH)D3. Interestingly, one of the consequences of culture with 1,25(OH)2D3 or 20S(OH)D3, was upregulation of the natural inhibitory receptor leukocyte associated immunoglobulin-like receptor-1 (LAIR-1 or CD305). Polyclonal antibodies which activate LAIR-1 were also capable of attenuating arthritis. Moreover, oral therapy with active forms of vitamin D suppressed arthritis in LAIR-1 sufficient DR1 mice, but were ineffective in LAIR-1−/− deficient mice. Taken together, these data show that the effect of vitamin D on inflammation is at least, in part, mediated by LAIR-1 and that non-calcemic 20S(OH)D3 may be a promising therapeutic agent for the treatment of autoimmune diseases such as Rheumatoid Arthritis.

9 September 2023 in Cytotherapy
Verified
Journal Article
Closed access
SASalem Akel
Salem Akel
LPLeigh Poston
Leigh Poston
JPJeoungeun John Park
Jeoungeun John Park
SSSusan B. Schoultz
Susan B. Schoultz
LALina Alloush
Lina Alloush
SGStephen Gottschalk
Stephen Gottschalk